Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bovine lactoferrin

This article was originally published in The Tan Sheet

Executive Summary

DMV International GRAS submission for milk-derived ingredient in sports and functional foods receives de facto affirmation from FDA. Initial notice, submitted by DMV in April 2000, was rejected by agency for lack of data, FDA letter notes. Agency shifts stance based on additional material submitted by DMV showing exposure to bovine lactoferrin does not increase individual's sensitivity to milk and lactoferrin's association with autoimmune disorders. Ingredient supplier continues to seek GRAS status for ingredient in infant formula

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel